Business trending topics
225 results
SPPI is, as the name suggests, a biopharma maker and developer. It produces Zevalin, Folotyn, and Fusilev, and actually turned those three drugs into $38 million worth of revenue last quarter (and $267 million worth of revenue last year). That's not what's ...Smallcap Network · ByJames E. Brumley · 5/23/2013
Bridgewater, MA -- (SBWIRE) -- 05/17/2013 -- Bridgewater, MA - The online StockConsultant latest screen has found a biotech company that developes drugs for hematology and oncology Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock under a …SBWire · 5/17/2013
I am long sppi, but there's no reason to get emotional about this until Raj makes the necessary announcements. A dividend is irrelevant here as it is paultry, as is the price fluctuation between 10-12. Shorts want to see this stock go down to 5 ...Yahoo! Finance · 5/19/2013
Year-to-date, however, the stock has fallen more than 28%. Shares of SPPI recently crossed above their 50-day moving average which suggests that market sentiment has turned bullish on the stock. The free report on SPPI can be downloaded by signing …Stockhouse · 5/21/2013
Find out if (SPPI) is in Cramer's Portfolio. NEW YORK (TheStreet Ratings) -- Every trading day TheStreet Ratings' stock model reviews the investment ratings on around 4,300 U.S. traded stocks for potential upgrades or downgrades based on the ...TheStreet.com · ByKevin Baker · 3/25/2013
Among the major movers were Celgene Corporation (NASDAQ: CELG), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Incyte Corporation (NASDAQ: INCY), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), and Geron Corporation (NASDAQ: GERN) …4-traders · 5/21/2013
Investors who are current long term stockholders in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares, have certain options and ... and as a result of defendants’ statements, Spectrum’s stock traded at artificially inflated prices between August ...SBWire · 5/14/2013
SAN DIEGO, March 20, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of Spectrum Pharmaceuticals, Inc. (SPPI) common stock over alleged violations of Federal ...Yahoo! Finance · 3/20/2013
In the last year, Blyth has lost almost 60% of its value. Yet despite trading with a price to sales of 0.22 shorts continue to pile into the stock, as shorts purchased 300,000 more shares in the month of April. Over the last month it has lost 13% of its ...beta.fool.com · 5/17/2013
Below are the three companies in the Biotechnology industry with the lowest enterprise value to EBITDA (EV/EBITDA) ratios. EV/EBITDA is an important metric used in valuing comparable companies. It is capital structure neutral and generally the lower the ...Financial News Network Online · ByMallory Stone · 5/20/2013
You might also like
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback